About this trial
The purpose of this observational study is to investigate the structure and composition of germinal centers in individuals with chronic HBV infection. The primary questions it aims to address are:
What are the phenotypes, functions, and complexity of B cell clones of the immune cells within the germinal centers of chronic HBV-infected individuals? Do chronic HBV-infected individuals have ectopic germinal centers in the liver? This will be studied by collecting peripheral blood and discarded liver, lymph node, and tonsil tissues from chronic HBV patients undergoing lymph node surgery, hepatectomy, and tonsillectomy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male or female, patients with chronic hepatitis B and hepatitis B surface antigen negative patients with clinical diagnosis who need to undergo liver, spleen, tonsil or lymph node surgery.
Before performing any research-related steps, the patient understood the research process, signed the informed consent, and complied with the research requirements.
Patients diagnosed with chronic hepatitis B virus infection according to the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B(2019 Version)" .
Disqualifiers
Those concomitant HCV, HIV infection, alcoholic fatty liver disease, non-alcoholic fatty liver disease, and autoimmune liver disease , etc. were excluded.
Diseases of the immune system or coagulation system, such as hyperthyroidism, diabetes, thrombocytopenic purpura, etc., were excluded.
Exclude serious underlying diseases that affect the immune status of the body.
The investigator believes that there are other circumstances that are not suitable for inclusion.
Trial population
The group of HBV patients who underwent liver, spleen, tonsil, and lymph node surgery and the group of HBV-negative patients who underwent liver, spleen, tonsil, and lymph node surgery
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Tissue resection
Procedure/SurgeryThe group of HBV patients who underwent liver, spleen, tonsil, and lymph node surgery and the group of HBV-negative patients who underwent liver, spleen, tonsil, and lymph node surgery
Treatment groups
Trial outcomes
Primary outcomes
The HBV-specific immune response levels will be measured using the immune cells from lymphoid follicle of the enrolled patients
Tissue section from the enrolled patients will be used to detect the levels of HBV-specific immunity and other laboratory indicators after restimulation with HBV peptide pools.
Secondary outcomes
Germinal center organization transcriptomics will be measured using the tissue section of the enrolled patients
We will utilize tissue samples and employ experimental methods such as immunohistochemistry, immunofluorescence, and spatial transcriptomics to measure the structure and size of germinal centers.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.